SOURCE: ISTA Pharmaceuticals

April 27, 2011 07:30 ET

ISTA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference

IRVINE, CA--(Marketwire - Apr 27, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will present at the Bank of America Merrill Lynch 2011 Health Care Conference at 10:00 a.m. Pacific Time on May 11, 2011, in Las Vegas, NV. ISTA's President and Chief Executive Officer Vicente Anido, Jr., Ph.D., will provide an update on the company's marketed products and clinical programs.

The presentation will be webcast. To access the live audio broadcast of the presentation, or the subsequent archived recording, log onto Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.


ISTA Pharmaceuticals, Inc. is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at

Contact Information